Return to the point in the document where this table is located.
| Contaminant | Health effects | Classification | Unit risk x 10-6 | Various guidelines (µg/m3) (annual averages unless otherwise stated) |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IARC* | US EPA* (potency) | WHO | US EPA | CARB | UK | EC | TWA/ 100 | WHO | US | ||
|
Benzene |
Haemotoxic; genotoxic; carcinogenic |
1 |
A (medium) |
4.4-7.5 |
8.3 |
29 |
18 (now) |
10 (now) |
18 |
- |
- |
|
1,3-Butadiene |
Neurological; irritation of eyes, throat, lungs and nose; mutagenic; carcinogenic (?) |
2A |
B2 (medium) |
- |
280 |
170 |
2.4 |
- |
24 |
- |
- |
|
Formaldehyde |
Irritation of eyes, throat, nose and respiratory symptoms; nasal cancer |
2A |
B1 (medium) |
Very low |
13 |
6 |
- |
- |
9.2 |
100 normal 10 hypersensitive (30-min) |
- |
|
Acetaldehyde |
Irritation of eyes, throat, nose and respiratory system; nasal cancer |
2B |
B2 (low) |
15-90 |
2.2 |
2.7 |
- |
- |
3600 |
2400 (24-hour) |
9 (RfC) |
|
Benzo(a)pyrene |
Dermatitis; photosensitisation; eye irritation; cataracts; lung cancer (?) |
1 |
B2 (medium) |
87,000 |
- |
- |
- |
- |
- |
- |
- |
|
Mercury** |
CNS; gastrointestinal; respiratory system; kidney |
2B(m) |
C (medium) |
- |
- |
- |
- |
- |
0.1(al) |
1(I) |
0.3(I) |
|
Chromium VI |
Respiratory; gastrointestinal; liver; kidney; immune system; blood |
1 |
A (high) |
11,000-130,000 |
1200 |
150,000 |
- |
- |
0.1-0.5 |
- |
0.0023 |
|
Chromium III and metal |
3 |
D |
- |
- |
- |
- |
- |
5.0 |
- |
- |
|
|
Arsenic (inorganic) |
Gastrointestinal; haemolysis; central and peripheral NS; eyes; skin; mucous membrane |
1 |
A (high) |
1500 |
4300 |
1500 |
- |
- |
0.1 |
- |
0.41 (REL) |
|
Arsine |
1.7 |
- |
0.055 (RfC) |
||||||||